These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32558716)

  • 1. Is It Time to Introduce PET/CT in Rectal Cancer Guidelines?
    Maffione AM; Montesi G; Caroli P; Colletti PM; Rubello D; Matteucci F
    Clin Nucl Med; 2020 Aug; 45(8):611-617. PubMed ID: 32558716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is It Time to Introduce PET/CT in Colon Cancer Guidelines?
    Maffione AM; Rubello D; Caroli P; Colletti PM; Matteucci F
    Clin Nucl Med; 2020 Jul; 45(7):525-530. PubMed ID: 32433179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study.
    Rutegård MK; Båtsman M; Axelsson J; Brynolfsson P; Brännström F; Rutegård J; Ljuslinder I; Blomqvist L; Palmqvist R; Rutegård M; Riklund K
    Cancer Imaging; 2019 Jul; 19(1):52. PubMed ID: 31337428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
    Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
    Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of
    Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y
    Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer.
    Davey K; Heriot AG; Mackay J; Drummond E; Hogg A; Ngan S; Milner AD; Hicks RJ
    Dis Colon Rectum; 2008 Jul; 51(7):997-1003. PubMed ID: 18461399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine Cervical Metastasis From Primary Rectal Adenocarcinoma on PET/CT and MRI.
    Chudgar AV; Mulugeta PG; Chauhan A; Dubroff JG
    Clin Nucl Med; 2016 Aug; 41(8):634-5. PubMed ID: 27276209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET/CT in colorectal cancer.
    Rodríguez-Fraile M; Cózar-Santiago MP; Sabaté-Llobera A; Caresia-Aróztegui AP; Delgado Bolton RC; Orcajo-Rincon J; de Arcocha-Torres M; García-Velloso MJ; García-Talavera P
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):57-66. PubMed ID: 31776063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental Finding of Endobronchial Metastasis by 18F-FDG PET/CT Leads to Change in Management in a Patient With Rectal Adenocarcinoma.
    Fabritius MP; Holzgreve A; Knösel T; Tiling R; Rübenthaler J
    Clin Nucl Med; 2020 Dec; 45(12):980-981. PubMed ID: 33065625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated Vaginal Recurrence of Early-Stage Rectal Cancer Detected by 18F-FDG PET/CT.
    Wang R; Fan Q; Liu H; Su M
    Clin Nucl Med; 2019 Jun; 44(6):499-500. PubMed ID: 30985425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal metastasis from rectal cancer detected by
    Fan Q; Huang D; Su M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):43-44. PubMed ID: 31862180
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.
    Gearhart SL; Frassica D; Rosen R; Choti M; Schulick R; Wahl R
    Ann Surg Oncol; 2006 Mar; 13(3):397-404. PubMed ID: 16485158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
    Rayamajhi S; Balachandran A; Katz M; Reddy A; Rohren E; Bhosale P
    Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penile metastasis from rectal cancer by PET/CT.
    Alzayed MF; Artho G; Nahal A; Hickeson M
    Clin Nucl Med; 2015 Apr; 40(4):e245-50. PubMed ID: 25546188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.
    Capirci C; Rubello D; Chierichetti F; Crepaldi G; Carpi A; Nicolini A; Mandoliti G; Polico C
    Biomed Pharmacother; 2004 Oct; 58(8):451-7. PubMed ID: 15464875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial M Staging of Rectal Cancer: FDG PET/MRI with a Hepatocyte-specific Contrast Agent versus Contrast-enhanced CT.
    Yoon JH; Lee JM; Chang W; Kang HJ; Bandos A; Lim HJ; Kang SY; Kang KW; Ryoo SB; Jeong SY; Park KJ
    Radiology; 2020 Feb; 294(2):310-319. PubMed ID: 31793850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic metastasis to the larynx detected by FDG PET/CT in a patient with recurrent rectal adenocarcinoma.
    Chen TY; Hung GU; Hung CC; Chiu JS; Kao CH
    Clin Nucl Med; 2012 Jul; 37(7):e178-80. PubMed ID: 22691530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigmented villous nodular synovitis mimicking metastases on
    Yen YA; Wu LC; Lu NM; Lee CH
    BMC Musculoskelet Disord; 2020 Jan; 21(1):13. PubMed ID: 31914975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.